Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine
Authors:
- Orp Ile de France OuestOOOrp Ile de France Ouest
- M. NakibMNM. Nakib
- C. PoyartCPC. Poyart
- J. RaymondJRJ. Raymond
- 18 April 2011
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 30 (12) , 1511-1519
Abstract
The purpose of this article was to describe the serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae strains isolated from adults and children with invasive disease (IPD) or acute otitis media (AOM) before introduction of the 13-valent pneumococcal vaccine. During 2009, 494 strains of S. pneumoniae isolated were collected. Complete serotyping by latex antisera and molecular methods was performed. The most frequent serotypes isolated from children with IPD were 1 (26.2%), 19A (25%) and 7F (14.3%). Serotype 19A was predominant (42.1%) in children ≤ 2 years, whereas serotype 1 was predominant (63.3%) after the age of 5. Serotype 19A was the most frequently isolated serotype from AOM (62.3%). In adults, serotypes responsible for IPD were 7F (19.4%), 19A (13.7%), 1 (8.4%) and 3 (7.5%). The serotype 19A was predominant in adults older than 65 years (19.1%). The emergence of serotype 12F was observed in adults. Between 2007 and 2009, the introduction of PCV-7 has resulted in a significant decrease of IPD caused by serotypes included in the vaccine, in children as well as in adults, confirming the herd effect. Serotype coverage of PCV-13 was 70% and 80.9% for adult and children’s IPD, respectively. PCV-13 will be more efficient in preventing invasive diseases among children and adults.Keywords
This publication has 36 references indexed in Scilit:
- Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for DiseaseClinical Infectious Diseases, 2010
- Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐AreaStreptococcus pneumoniaeResearch (CASPER) StudyClinical Infectious Diseases, 2009
- Serotype Coverage of Invasive and Mucosal Pneumococcal Disease in Israeli Children Younger Than 3 Years by Various Pneumococcal Conjugate VaccinesThe Pediatric Infectious Disease Journal, 2009
- The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children.2008
- Large Community Outbreak ofStreptococcus pneumoniaeSerotype 5 Invasive Infection in an Impoverished, Urban PopulationClinical Infectious Diseases, 2008
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Postvaccine Genetic Structure ofStreptococcus pneumoniaeSerotype 19A from Children in the United StatesThe Journal of Infectious Diseases, 2005
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Epidemiologic Studies of Streptococcus pneumoniae in Infants: Acquisition, Carriage, and Infection during the First 24 Months of LifeThe Journal of Infectious Diseases, 1980